$0.87 EPS Expected for MSA Safety (MSA), Mirna Therapeutics (MIRN) Had 1 Bulls

June 26, 2017 - By Ellis Scott

Analysts expect MSA Safety Incorporated (NYSE:MSA) to report $0.87 EPS on July, 19.They anticipate $0.08 EPS change or 10.13% from last quarter’s $0.79 EPS. MSA’s profit would be $33.02M giving it 23.09 P/E if the $0.87 EPS is correct. After having $0.58 EPS previously, MSA Safety Incorporated’s analysts see 50.00% EPS growth. The stock decreased 0.22% or $0.18 on June 23, reaching $80.35. About shares traded. MSA Safety Incorporated (NYSE:MSA) has risen 64.52% since June 26, 2016 and is uptrending. It has outperformed by 47.82% the S&P500.

Among 5 analysts covering Mirna Therapeutics (NASDAQ:MIRN), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Mirna Therapeutics had 8 analyst reports since October 26, 2015 according to SRatingsIntel. The stock of Mirna Therapeutics Inc (NASDAQ:MIRN) earned “Perform” rating by Oppenheimer on Wednesday, September 21. The stock of Mirna Therapeutics Inc (NASDAQ:MIRN) has “Hold” rating given on Wednesday, September 21 by Cantor Fitzgerald. The rating was initiated by Oppenheimer with “Outperform” on Monday, October 26. Cantor Fitzgerald initiated the stock with “Buy” rating in Monday, October 26 report. H.C. Wainwright downgraded Mirna Therapeutics Inc (NASDAQ:MIRN) on Friday, September 23 to “Neutral” rating. On Thursday, September 22 the stock rating was maintained by Citigroup with “Neutral”. The stock of Mirna Therapeutics Inc (NASDAQ:MIRN) earned “Outperform” rating by Leerink Swann on Monday, October 26. See Mirna Therapeutics Inc (NASDAQ:MIRN) latest ratings:

Mirna Therapeutics, Inc. is a clinical-stage biopharmaceutical firm developing a pipeline of micro ribonucleic acid oncology therapeutics. The company has market cap of $27.90 million. The Firm is developing mimics of naturally occurring microRNAs that are designed to restore the tumor suppressor activity and aid appropriate anti-tumor immune response. It currently has negative earnings. This approach is known as microRNA replacement therapy.

The stock decreased 7.10% or $0.11 on June 23, reaching $1.44. About shares traded. Mirna Therapeutics Inc (NASDAQ:MIRN) has declined 67.97% since June 26, 2016 and is downtrending. It has underperformed by 84.67% the S&P500.

Investors sentiment increased to 2.04 in 2016 Q4. Its up 1.03, from 1.01 in 2016Q3. It increased, as 7 investors sold MSA Safety Incorporated shares while 39 reduced holdings. 23 funds opened positions while 71 raised stakes. 23.25 million shares or 2.64% more from 22.65 million shares in 2016Q3 were reported. Strs Ohio accumulated 900 shares. State Board Of Administration Of Florida Retirement Sys stated it has 10,991 shares. Washington-based Parametric Associate Ltd Liability has invested 0.01% in MSA Safety Incorporated (NYSE:MSA). D E Shaw And Incorporated reported 0% of its portfolio in MSA Safety Incorporated (NYSE:MSA). Martingale Asset Management L P accumulated 85,420 shares. 600 were reported by Da Davidson And. Raymond James Fin Serv Incorporated, a Florida-based fund reported 16,267 shares. 65,939 are owned by Citigroup Inc. Barrow Hanley Mewhinney And Strauss Ltd invested in 91,863 shares or 0.01% of the stock. Tower Research Cap Ltd Limited Liability Company (Trc) has invested 0.01% in MSA Safety Incorporated (NYSE:MSA). Clifford Swan Counsel Ltd Liability Com holds 3,960 shares. Smithfield Tru holds 540 shares. Pennsylvania-based Pnc Services Grp Inc Inc Inc has invested 0.01% in MSA Safety Incorporated (NYSE:MSA). Comerica Bank invested in 23,079 shares. Aqr Ltd Liability Com reported 3,888 shares stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.